...Peter Hasler as COO, effective Oct. 1, while retiring as non-executive director, currently chairman of HBM BioVentures...

...but will retire from the board when he becomes COO. Hasler is currently chairman of HBM Bioventures...

...completed: 7/23/12 Type: Venture financing Raised: $30 million Investors: Credit Suisse First Boston Private Equity; HBM BioVentures...

...Plainfield, N.J.) raised $30 million from existing investors, including Credit Suisse First Boston Equity Partners; HBM BioVentures...

...which has raised at least $66 million. Its syndicate includes Clarus Ventures; Novo A/S; and HBM BioVentures...

...Tending the stable HBM BioVentures (SIX:HBMN) won't be making new investments this fiscal year, CEO Andreas Wicki...
...making sure that our most promising companies are fed well," Wicki said. About 42% of HBM BioVentures'...
...CHF35.8 million (6.6%). Pacira shares added 63% during HBM's fiscal year. Basilea shed 23%, but HBM BioVentures...

...in the U.S. Investors include GSK (24.4% pre-IPO stake); Techne Corp. (19.7%); OrbiMed Advisors (11%); HBM BioVentures...

...Ventures; Edmond de Rothschild Investment Partners; LSP-Life Sciences Partners; Biogen Idec New Ventures; TVM Capital; HBM BioVentures...

...Ventures; Edmond de Rothschild Investment Partners; LSP-Life Sciences Partners; Biogen Idec New Ventures; TVM Capital; HBM BioVentures...

...directors to the biotech's five-member board on Nov. 29 at a meeting requested by shareholder HBM BioVentures...